Master's in Pharmacy

		Study programme 2020-2021	Français
		Technologie pharmaceutique: galénique & biopharmacie
		Programme component of Master's in Pharmacy à la Faculty of Medicine and Pharmacy

Students are asked to consult the ECTS course descriptions for each learning activity (AA) to know what special Covid-19 assessment methods are possibly planned for the end of Q3

Code	Type	Head of UE	Department’s contact details	Teacher(s)
UM-M1-PHARMA-006-M	Compulsory UE	VANDERBIST Francis	M111 - Pharmacie Galénique	VANDERBIST Francis

Language of instruction	Language of assessment	HT(*)	HTPE(*)	HTPS(*)	HR(*)	HD(*)	Credits	Weighting	Term
Français	Français	50	0	0	0	0	5	5.00	1st term

AA Code	Teaching Activity (AA)	HT(*)	HTPE(*)	HTPS(*)	HR(*)	HD(*)	Term	Weighting
M-DOYM-088	Technologie Pharmaceutique: galénique & biopharmacie	50	0	0	0	0	Q1	100.00%

Programme component

Objectives of Programme's Learning Outcomes

Learning Outcomes of UE

Detailed knowledge and theoretical understanding of the various pharmaceutical compositions and of Biopharmacy.
+ knowledge and abilities of magistral preparations.

Content of UE

Course' plan of Pharmaceutical forms and Biopharmacy (MA1)
Full-time Lecturer - Francis Vanderbist

PART 1 (Q1 : 09-12/2020)

Preface
Introduction to Good Manufacturing Practices (GMP) and notions of Quality Assurance (QA)
Chapter 1: Biopharmacy
Chapter 2: Préformulation studies
Chapter 3: Stability studies of pharmaceutical compositions
Chapter 4: Pharmaceutical solutions
Chapter 5: Pharmaceutical emulsions
Chapter 6: Pharmaceutical suspensions
Chapter 8: Ophtalmical formulations
Chapter : Rectals et vaginals pharmaceutical compositions
Chapitre 10: Ear compositions

PARTIE 2 (Q2 : 01-03/2021)

Chapitre 11 : Poudres et notions d'écoulement
Chapitre 12 : Les gélules et les capsules molles pharmaceutiques
Chapitre 13 : Comprimés pharmaceutiques conventionnels
Chapitre 14 : Formes pharmaceutiques enrobées
Chapitre 15 : Formes pharmaceutiques à libération contrôlée
Chapitre 16 : Formes transdermiques
Chapitre 17 : Délivrance pulmonaire des médicaments
Chapitre 18 : Formes pharmaceutiques parentérales
Chapitre 19 : Conditionnement et stabilité des médicaments

Prior Experience

Notions of Pharmacology
Good Physico-Chemical Knowledge (theory and practical)
Good Knowledge in Pharmaceutical Analysis (theory and practical)

Type of Assessment for UE in Q1

Oral examination

Q1 UE Assessment Comments

Oral exam Q1: aimed to a detailed evaluation of the global knowledge and understanding of all chapters teached in Q1 period.
Oral exam Q1: 100 % of Q1 quotation

Type of Assessment for UE in Q3

Oral examination
Practical Test

Q3 UE Assessment Comments

Oral Exam for Q3: aimed to a detailed evaluation of the global knowledge and understanding of all chapters teached in Q3 period.
Practical Work = 20 % of the total quotation

If the theoretical quotation is less than 50% (< 8/16), lthe quotation of the practical work will not be taken into account

Type of Resit Assessment for UE in Q1 (BAB1)

Q1 UE Resit Assessment Comments (BAB1)

Not applicable

Type of Teaching Activity/Activities

AA	Type of Teaching Activity/Activities
M-DOYM-088	Cours magistraux

Mode of delivery

AA	Mode of delivery
M-DOYM-088	Mixed

Required Reading

AA
M-DOYM-088

Required Learning Resources/Tools

AA	Required Learning Resources/Tools
M-DOYM-088	Not applicable